Related Experiment Video

Updated: Jun 16, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Inhibition of mitochondrial translocator protein prevents atrial fibrillation

Jun Li1, Junjie Xiao, Dandan Liang

  • 1Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.

European Journal of Pharmacology
|February 4, 2010
PubMed

Insights

Targeting mitochondrial translocator protein (TSPO) effectively reduced atrial fibrillation incidence in rabbit models. TSPO inhibition also improved cellular calcium and ATP levels, suggesting it as a novel therapeutic target for atrial fibrillation.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Atrial fibrillation is a common arrhythmia with severe complications like heart failure and stroke.
  • Identifying effective therapeutic targets for atrial fibrillation remains a significant clinical challenge.

Purpose of the Study:

  • To investigate the role of mitochondrial translocator protein (TSPO) in different types of atrial fibrillation.
  • To evaluate the therapeutic potential of TSPO inhibition for atrial fibrillation.

Main Methods:

  • Development of in vitro rabbit heart models for ischemia-, stretch-, and cholinergic agitation-induced atrial fibrillation.
  • Pharmacological inhibition of TSPO.
  • Monitoring intracellular Ca(2+) and ATP levels using Fura-2 AM and Mg(2+)-Fura-2 AM in HL-1 cells.

Main Results:

  • TSPO inhibition significantly reduced the incidence of all three induced atrial fibrillation models.
  • Inhibition of TSPO ameliorated cytoplasmic Ca(2+) overload and energy compromise in HL-1 cells subjected to chemical ischemia or cholinergic agitation.

Conclusions:

  • TSPO plays a crucial role in various forms of atrial fibrillation.
  • TSPO represents a promising and common molecular target for novel atrial fibrillation treatments.

More Related Videos

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction08:31

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction

Published on: July 26, 2018

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...